Genetic Test: CAG Repeat Analysis for CACNA1A Gene (Specified Variant)
This test checks the number of repeated CAG sequences in the CACNA1A gene, which may be linked to certain neurological conditions.
This genetic test helps assess potential risks for inherited disorders affecting movement and muscle control.
Key facts at a glance
- LOINC
- 49649-7
- Short code
- CACNA1A1
- Synonyms
- CACNA1A allele 1 CAG Rpt EntNum Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (lavender/purple-top) blood collection tube for whole blood; sterile container for tissue samples
- Units
- N/A
- Ref low
- 4
- Ref high
- 20
- Critical range
- — – 20 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–999 years
- Method
- molgen
- CPT
- 81343
- SNOMED
- 444911005
- Specimen volume
- 5-10 mL whole blood in EDTA tube; minimum 3 mL. Tissue samples: minimum 25 mg fresh tissue or equivalent
- Stability
- Whole blood: Stable at room temperature (18-25°C) for up to 48 hours; refrigerated (2-8°C) for up to 7 days; frozen (-20°C or below) for long-term storage. DNA extracted from blood: stable at 2-8°C for 1 week or -20°C for long-term.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 168–720 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may recommend this test if you have a family history of conditions like epilepsy, ataxia, or other neurological disorders associated with CACNA1A gene mutations. It may also be used for genetic counseling or carrier screening in certain situations.
What to Expect During the Test
A simple blood sample is typically taken from a vein in your arm. The sample is then sent to a lab for genetic analysis. Results are usually available within a few weeks.
Understanding Your Results
The test measures the length of the CAG repeat sequence in the CACNA1A gene. Normal ranges vary, and abnormal findings may indicate an increased risk for neurological conditions. Consult your healthcare provider for interpretation.
Clinical Significance
Abnormal CAG repeat lengths in the CACNA1A gene can be associated with conditions such as epilepsy, cerebellar ataxia, or other movement disorders. Genetic testing helps identify carriers or individuals at higher risk for these conditions, guiding family planning and management strategies.
Reference range
Normal CACNA1A CAG repeat range: Allele 1 typically contains 4-20 CAG repeats in the coding region. Repeat expansions beyond 20 CAG repeats are associated with spinocerebellar ataxia type 6 (SCA6) and other CACNA1A-related disorders. Intermediate alleles (20-32 repeats) may have variable penetrance.N/A
No special patient preparation required. Genetic counseling is recommended before and after testing. Informed consent for genetic testing may be required per institutional policy.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Abnormal results may require further genetic counseling and may influence family planning decisions or recommendations for monitoring.
Short name
CACNA1A Gene CAG Repeat Test
Frequently asked questions
What does a 'qualitative' or 'quantitative' result mean in this test?
How long does it take to get my test results?
Can this test be done on saliva instead of blood?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy